ACIR

acir-org.bsky.social

16 July 2026 18:50

Mestrallet et al. focused on resistance mechanisms that limit anti-PD-1 efficacy in colorectal cancer (50% to 100% failure depending on mismatch repair status). bit.ly/49qWVm8 @sinaiimmuno.bsky.social @gmestrallet.bsky.social @bhardwajlab.bsky.social

The Drew Weissman Lab

drewweissmanlab.bsky.social

06 April 2026 14:35

New article! 👏One-component ionizable amphiphilic Janus dendrimers as a delivery platform for efficient mRNA vaccine development | Science Advances www.science.org/doi/10.1126/...

Waggoner Lab

labwaggoner.bsky.social

05 March 2026 20:24

Preprint: Targeting Neoantigens Conserved Across Organs and Species Overcomes Tumor Immune Escape @bhardwajlab.bsky.social @sinaiimmuno.bsky.social papers.ssrn.com/sol3/papers....

Nicolas Vabret

neoviral.bsky.social

30 September 2025 08:02

Check out our latest in @cp-trendscancer.bsky.social where rockstar PhD student @laurarosenberg.bsky.social reviews cancer therapies known to induce innate immune responses through the reactivation of Transposable Elements.

Samarth Hegde

samhegde.bsky.social

07 March 2025 22:02

New York out in force ! Science matters for EVERYONE ! #standupforscience2025